Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)
- How to effectively adopt AI tools in the CGT space
- Opportunities for AI and machine learning in process development & manufacturing
- Real-world applications of AI in CGT pipeline development
- Case study insights on AI-driven innovation
- Shashi Murthy - CTO and Co-Founder, Nanite Inc.
- Pauline Schmit - Senior Scientist, Preclinical Research, nChroma Bio
- Mahesh Bule - Associate Director, Kite Pharma a Gilead Company
- Amy Shaw - Head of Process and Product Development, Takeda, USA
- Mark Farmery - Chief Development Officer, Anocca AB
- Defining point-of-care manufacturing and decentralized manufacturing
- Scaling with consistency: key elements for global standardization
- Tech & innovation: cutting-edge solutions for safe, efficient, and cost-effective decentralized manufacturing
- Overcoming obstacles to decentralised manufacturing to enable access to approved CGTs
- Differences in systems across decentralized cell therapy manufacturing models - how can we harmonize?
- Standardization vs a modular approach
- Equipment, data, and technologies
- Dialogue and collaboration between developer/practitioner to streamline eventual implementation
- Improving worldwide access: how can local manufacturers and supplier help?
- Real world experience with a decentralized cell therapy manufacturing platforms supporting Phase I/II clinical trials
- Francesca Vitelli, PhD - Former, VP Cell Therapy and Viral Vector PD and MSAT, Intellia Therapeutics, Inc
- Ying Cai - MSAT Executive Director, Ultragenyx Pharmaceutical
- Nripen Singh - Head of Process Development, TRD CGT, Novartis
- Phillip Ramsey - Senior Vice President, Technical Operations, Sangamo Therapeutics
- Jordan Ball - Sr. Manager, Technology Transfer, Regeneron
- Kristy Wood - SVP, Technical Operations, Intellia Therapeutics
- Devyn Smith - CEO, Arbor Biotechnologies
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Shawn (Xueyuan) Wang - Director, Process Development, Kite Pharma
- Wonjong Si - Associate Director, Cell Therapy Platform Process, Bayer
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Improvements and innovations in cell line development & engineering to increase yields for gene therapies
- Application of producer cell lines to lower transfection vector costs: Data for large scale use of stable cell lines
- Scalability of producer cell lines? Case studies on experiences at larger scales
- Huize Yan - Sr. Process Development Scientist – Upstream, Spark Therapeutics
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Ratnesh Joshi - Associate Director, Downstream Process Development, Editas Medicine
- Weiyi Li - Senior Manager, LNP Formulation, Prime Medicine, Inc.
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Shashi Prajapati - Director, Cell & Gene Therapies Analytical Development, Vertex Pharmaceuticals
- Lena Yang - Senior Scientist, Cell Therapy Analytical Development, Takeda
- Mariska ter Haak - Senior Director Analytical Development, IN8bio
A Representative from Solvias
- David Dobnik - Scientific Associate, National Institute of Biology
- Hunter Reese - Scientist II, AskBio
- Junfen Ma - Head of Genomic Medicine Purification Process Development, Sanofi
- Hana Jug - Product Manager (Enveloped viruses, VLPs and EVs), Sartorisu BIA Separations
- Shankar Swaminathan, PhD - Team Lead, Drug Product Development, CMC-Tech Ops, Astellas Institute for Regenerative Medicine
- Jeffrey Masten - Senior Vice President CMC, Secretome Therapeutics
- Matthew Provencal - Executive Director Gene Therapy BDS Manufacturing, Sarepta
- Dong Xu, Ph.D. - Associate Director, Cell Therapy Analytical Development, TScan Therapeutics
- Dana Schreffler - Sr. Manager QC Viral Safety, Regeneron
- Parag Kumthekar - Gene Therapy Downstream Process Development Lead, UCB Pharma